Europe Atherectomy Devices Market

Europe Atherectomy Devices Market Size (2023 to 2028)

The atherectomy devices market size in Europe is predicted to be worth USD 94.58 million in 2023 and USD 131.11 million by 2028, growing at a CAGR of 6.75% from 2023 to 2028 owing to the rising prevalence of chronic diseases among the people, such as peripheral artery ailments, cardiovascular diseases, cerebrovascular diseases, and other diseases. The rising adoption of sedentary lifestyles, unhealthy eating and alcohol consumption by the European population is resulting in the incidence of lifestyle-related diseases among people and contributing to the market growth in Europe. 

The growing geriatric population is significantly contributing to the Atherectomy devices market. In addition, as the senior population is more prone to various chronic diseases, thereby increases the demand for Atherectomy devices. In addition, the technological advancements in developing new advanced devices and products, the rising initiatives for the development of the device, and healthcare devices are fuelling the market growth. 

Moreover, increasing awareness about atherectomy devices among people as these procedures help remove plaque from blood vessels. Furthermore, boosting investment and funding from government and non-government in research and development activities for new innovative devices and procedures is propelling atherectomy devices' market growth. The preferences towards minimally invasive surgical procedures increase rapidly due to benefits such as faster recovery rates, lesser pain, and high accuracy rates.

The growing costs of installation and maintenance of the devices with some complications and issues related to atherectomy devices and the risk of forming an embolus (blockage) from the dislodged debris are restraining the market's growth. In addition, the lack of skilled and trained professionals for operating and monitoring the devices and the stringent government rules and regulations make the entry of the product difficult due to strict approval processes for approving devices and services, which slows down the growth of atherectomy devices in the European market.

This research report on the European atherectomy devices market has been segmented and sub-segmented into the following categories:

By Type: 

• Directional
• Rotational
• Orbital
• Lateral

By Application: 

• Peripheral
• Cardiovascular
• Neurovascular

By End User: 

• Hospitals
• Surgical Centers
• Research Laboratories
• Academic Institutes

By Country: 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

The Europe Atherectomy Devices Market is expected to show a significant growth rate in the forecast period due to increased healthcare expenditure and the growing importance of medical technology research. The market growth is further expected to be driven by the increasing population, with the rising geriatric population is increasing the demand for atherectomy devices in the market. Also, an increase in chronic diseases such as peripheral diseases, neurovascular diseases, cardiovascular diseases, and other diseases are driving the market growth. The growth contributors in the region are Germany, the UK, France, Italy, and Spain are expanding the European regional market growth.

Germany accounted for the largest share of the European atherectomy devices market and is anticipated to record a prominent share during the forecast period. The market growth is driven by increased government initiatives for developing advanced medical and healthcare infrastructure, research and development activities, and the prevalence of chronic diseases.

On the other hand, emerging countries such as UK and France are expected to register a considerable share owing to the growing focus towards advancements in the technology for developing advanced and effective devices with the increase in proper and favorable reimbursement policies. Also, growing awareness about the benefits of atherectomy devices among people is increasing market growth.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the European atherectomy devices market profiled in this report are Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Avinger, Inc., Boston Scientific Corporation, Straub Medical AG, St. Jude Medical, Cardiovascular Systems, Inc., and Spectranetics.